Dendritic cell maturation with CpG for tumor immunotherapy (original) (raw)
99 Dendritic Cell Maturation with CpG for Tumor
samaneh arab
2015
View PDFchevron_right
Reduced efficacy of multiple doses of CpG-matured dendritic cell tumor vaccine in an experimental model
Reza Mirzaei
Cellular Immunology, 2011
View PDFchevron_right
Immunotherapeutic Potential of Tumor Antigen-Pulsed and Unpulsed Dendritic Cells Generated from Murine Bone Marrow
Timothy Darrow
Cellular Immunology, 1997
View PDFchevron_right
Increased Numbers of Monocyte-Derived Dendritic Cells during Successful Tumor Immunotherapy with Immune-Activating Agents
Joanna Kirman, Franca Ronchese
The Journal of Immunology, 2013
View PDFchevron_right
Labeur MS, Roters B, Pers B et al.Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J Immunol 162:168-175
Annette Mehling
The Journal of Immunology
View PDFchevron_right
Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma
amla Chopra
Anticancer research
View PDFchevron_right
Active immunization using dendritic cells mixed with tumor cells inhibits the growth of primary breast cancer. Discussion
Eamonn Coveney
Surgery, 1997
View PDFchevron_right
Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response
Danuta Duś
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society, 2007
View PDFchevron_right
Protective anti-tumour immune responses by murine dendritic cells pulsed with recombinant Tat-carcinoembryonic antigen derived from Escherichia coli
SY Seong
Clinical & Experimental Immunology, 2009
View PDFchevron_right
Immunity to squamous carcinoma in mice immunized with dendritic cells transfected with genomic DNA from squamous carcinoma cells
Lauren Ng
Cancer Gene Therapy, 2005
View PDFchevron_right
Dendritic cell preparation for immunotherapeutic interventions
Marc Grégoire
2009
View PDFchevron_right
Dendritic Cells for the Immunotherapy of Cancer
Atique Ahmed
Clinical Oncology, 2002
View PDFchevron_right
A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model
Ananda Mookerjee
BioImpacts
View PDFchevron_right
Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice
Asim Saha
International Journal of Cancer, 2009
View PDFchevron_right
Unpulsed dendritic cells induce broadly applicable anti-tumor immunity in mice
Albert DeLeo
Cancer Biology & Therapy, 2005
View PDFchevron_right
Optimization of Production of Anti-Cancer Vaccines Based on Dendritic Cells
Zélia Silva
2015
View PDFchevron_right
Active immunization using dendritic cells mixed with tumor cells inhibits the growth of primary breast cancer
Eamonn Coveney
Surgery, 1997
View PDFchevron_right
Cellular Immunotherapy with Dendritic Cells in Cancer: Current Status
Peter Brossart
Stem Cells, 2004
View PDFchevron_right
Generation of Tumor Immunity by Bone Marrow-Derived Dendritic Cells Correlates with Dendritic Cell Maturation Stage
Annette Mehling
Journal of Immunology, 1999
View PDFchevron_right
Induction of an antitumor response using dendritic cells transfected with DNA constructs encoding the HLA-A*02:01- restricted epitopes of tumor-associated antigens in culture of mononuclear cells of breast cancer patients
Elena Gavrilova, Vasily Kurilin
View PDFchevron_right
Dendritic cells and tumor immunity
Georg Varga
Seminars in Immunology, 2001
View PDFchevron_right
Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer
Carole Bourquin
International Journal of Cancer, 2006
View PDFchevron_right
Active immunotherapy for cancer patients using tumor lysate pulsed dendritic cell vaccine: a safety study
Ercument Ovali
Journal of experimental & clinical cancer research: CR
View PDFchevron_right
Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer Vaccines
Peter Raspor
Journal of Experimental Medicine, 2000
View PDFchevron_right
Dendritic Cells in Antitumor Immune Responses
Jay Berzofsky
Cellular Immunology, 1996
View PDFchevron_right
In vitro Production of Dendritic Cells as Cancer Immunotherapy: Highlights on Sample Source, Culture Period, Differentiation and Maturation Cytokines
Cynthia Sartika
2023
View PDFchevron_right
Results of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer
Alfonso Yubero, Ramon Sousa, Antonio Güemes
Tumori
View PDFchevron_right
Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge
Franca Ronchese
Cancer Immunology, Immunotherapy, 1997
View PDFchevron_right
On dendritic cell-based therapy for cancers
Fazle Akbar
Journal of Zhejiang University-SCIENCE B, 2005
View PDFchevron_right